Insights

Global Launch Capabilities Adalvo has demonstrated extensive experience in executing complex and high-value pharmaceutical launches across multiple regions including Asia, Europe, North America, and the Middle East, indicating strong operational capacity and strategic partnerships suited for expanding product pipelines into new markets.

Innovative Product Portfolio The company's recent launches of high-demand medications such as Rivaroxaban, Pregabalin PR, and Dapagliflozin, along with upcoming launches like Teduglutide and Azelastine/Fluticasone spray, highlight an active pipeline focused on specialty and blockbuster therapies, presenting opportunities for partners seeking market entry or expansion.

Strategic Market Focus Adalvo’s targeted launches across key European markets and plans for broad Asian and American penetration offer sales opportunities tailored to regional healthcare trends and payer landscapes, making it an attractive partner for companies aiming to access diverse markets with high-growth potential.

Strong Industry Position As a leading B2B pharmaceutical partner with collaborations spanning over 100 countries and more than 140 commercial partners, Adalvo’s reputation and global reach can facilitate joint ventures, licensing deals, or co-marketing efforts aimed at accelerating market access for new or existing products.

Growing Market and Revenue With reported revenues between 10 million and 50 million dollars and expanding product launches, Adalvo is positioned for growth, offering sales teams an opportunity to target a rapidly evolving company with a broadening portfolio and increasing market presence in both established and emerging regions.

Adalvo Tech Stack

Adalvo uses 8 technology products and services including Amazon S3, Open Graph, Cookiebot, and more. Explore Adalvo's tech stack below.

  • Amazon S3
    Content Delivery Network
  • Open Graph
    Content Management System
  • Cookiebot
    Cookie Compliance
  • Webpack
    Development
  • Microsoft Excel
    Editors
  • dc.js
    Javascript Graphics
  • Microsoft Azure
    Platform As A Service
  • CSS
    Web Tools And Plugins

Media & News

Adalvo's Email Address Formats

Adalvo uses at least 1 format(s):
Adalvo Email FormatsExamplePercentage
First.Last@adalvo.comJohn.Doe@adalvo.com
47%
Last.First@adalvo.comDoe.John@adalvo.com
3%
First.Last@adalvo.comJohn.Doe@adalvo.com
47%
Last.First@adalvo.comDoe.John@adalvo.com
3%

Frequently Asked Questions

Where is Adalvo's headquarters located?

Minus sign iconPlus sign icon
Adalvo's main headquarters is located at Malta Life Science Park, Building 1 Level 4 San Gwann, SGN 3000, MT. The company has employees across 3 continents, including EuropeAsiaSouth America.

What is Adalvo's official website and social media links?

Minus sign iconPlus sign icon
Adalvo's official website is adalvo.com and has social profiles on LinkedIn.

What is Adalvo's NAICS code?

Minus sign iconPlus sign icon
Adalvo's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Adalvo have currently?

Minus sign iconPlus sign icon
As of October 2025, Adalvo has approximately 246 employees across 3 continents, including EuropeAsiaSouth America. Key team members include Chief Operations Officer: A. K.Chief Intellectual Property Officer: T. S.Chief Financial Officer: M. D.. Explore Adalvo's employee directory with LeadIQ.

What industry does Adalvo belong to?

Minus sign iconPlus sign icon
Adalvo operates in the Pharmaceutical Manufacturing industry.

What technology does Adalvo use?

Minus sign iconPlus sign icon
Adalvo's tech stack includes Amazon S3Open GraphCookiebotWebpackMicrosoft Exceldc.jsMicrosoft AzureCSS.

What is Adalvo's email format?

Minus sign iconPlus sign icon
Adalvo's email format typically follows the pattern of First.Last@adalvo.com. Find more Adalvo email formats with LeadIQ.

When was Adalvo founded?

Minus sign iconPlus sign icon
Adalvo was founded in 2020.
Adalvo

Adalvo

Pharmaceutical ManufacturingMalta201-500 Employees

Adalvo is a global pharmaceutical company, and one of the leading B2B pharmaceutical companies in Europe, with commercial partnerships in more than 100 countries and for over 140 commercial partners globally. The company’s declared purpose is to make a difference for patients all over the world, driven by our smart collaboration network and commitment to delivering highest quality differentiated products and services to our partners. With headquarters in Malta, the company presence in more than 15 countries such as Switzerland, UK, Netherlands, Spain, Iceland, Austria, Romania, Hungary, Bulgaria, Turkey, Italy, Czech Republic, Uruguay, Slovenia and India. At Adalvo, we know that our partners like to be bigger, better and smarter in the dynamic pharmaceutical sector. That’s why our approach is unique, customized to our partners, and is designed to challenge the status quo: together, this helps our partners achieve their business goals. We take pride in our ability to help its partners reach their goals – be those increasing revenues or pushing into new markets. While partners are a high priority, Adalvo is also committed to its purpose and mission to accelerate the growth and development of employees and local communities. Adalvo tirelessly strives for excellence in all of its endeavours, driven by a deep-rooted passion to making a difference for partners. The company’s purpose driven culture is committed to improving the lives of patients around the world. Our dynamic leadership team brings significant experience and industry know-how to Adalvo, which has helped to establish the company as a reliable global partner.

Section iconCompany Overview

Headquarters
Malta Life Science Park, Building 1 Level 4 San Gwann, SGN 3000, MT
Website
adalvo.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2020
Employees
201-500

Section iconFunding & Financials

  • $500M$1B

    Adalvo's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $500M$1B

    Adalvo's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.